Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CardioOptics was a medical device company that developed infrared-based visualization technology for use in cardiac surgery and interventional cardiology. Its primary product, the Trans-Blood Visualization System (TBVS), allowed clinicians to see through blood in real-time during minimally invasive procedures. This technology was designed to improve the accuracy of treatments for conditions like atrial fibrillation by providing direct visualization of the heart's internal structures. The company was based in Boulder, Colorado, and focused on integrating its optical systems with existing catheters and surgical tools. Despite receiving regulatory clearance for its initial systems, the company is no longer active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CardioOptics.